研究进展和应用进展关于从M2巨中获得的外体中的miRNA用于组织损伤修复的研究进展和应用进展
Zhikang Zhu1, Xinge Zhang1, Xuran Lin1
1Department of Plastic Surgery, The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, Zhejiang University, Yiwu, Zhejiang, People's Republic of China.
International journal of nanomedicine
|February 10, 2025
概括
携带microRNAs (miRNAs) 的M2巨细胞衍生外体 (M2-Exos) 是组织修复的关键. 本综述详细介绍了它们的功能和治疗潜力,用于治疗各种伤害.
科学领域:
- 再生医学是一种再生医学.
- 细胞生物学 细胞生物学
- 免疫学 免疫学 免疫学
背景情况:
- 组织修复涉及复杂的免疫细胞相互作用,M2巨细胞发挥着至关重要的作用.
- 由M2巨细胞衍生的外体 (M2-Exos) 通过微RNA (miRNAs) 调解细胞间的通信,影响组织再生.
- 了解这些机制对于开发再生疗法至关重要.
研究的目的:
- 审查外体生物发生,miRNA合成和功能以及外体提取方法.
- 总结M2-ExosmiRNAs在各种生物系统的组织修复中的各种功能和机制.
- 探索M2-Exos在疾病预防,诊断和临床实践中的潜在应用.
主要方法:
- 对外体生物学和miRNA功能的文献综述.
- 在不同组织修复模型中对M2-Exos的研究分析.
- 综合关于治疗应用和挑战的当前研究.
主要成果:
- M2-Exos提供特定的miRNAs,调节组织修复所必需的细胞过程.
- 这些外体已经在各种伤害模型中证明了促进愈合的有效性.
- 确定了参与M2-Exo介导修复的关键miRNA及其点.
结论:
- M2-Exos代表了一种有前途的无细胞治疗策略,用于组织损伤的修复.
- 需要进一步的研究来优化外体取和临床应用的效率和安全性.
- 在再生医学中M2-Exos的治疗潜力是显著的,但需要进一步验证.
相关概念视频
MicroRNAs
21.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Mesenchymal Stem Cells
4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K


